29th Oct 2010 15:15
RNS Number : 2818V
ValiRx PLC
29 October 2010
ValiRx Plc
("ValiRx" or the "Company")
Change of adviser
The Board of ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, is pleased to announce the appointment of Cairn Financial Advisers LLP as Nominated Adviser and Hybridan LLP as sole broker with immediate effect.
Enquiries:-
ValiRx plc Dr. Satu Vainikka | Tel: +44 (0) 20 3008 44 |
Cairn Financial Advisers LLP Nominated Adviser Tony Rawlinson / Liam Murray | Tel:+44(0)20 7148 7900 |
Hybridan LLP Broker Claire Noyce | Tel:+44(0)207 7947 4350 |
Peckwater PR Tarquin Edwards | Tel: +44 (0)7879 458 364 |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
ValiRx